Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
$1.58−0.08 (-4.82%)
Close on Nov 13, 2026Market cap $561.78MP/E –Yield –
Evotec total assets
Total assets on the balance sheet at the end of each period.
Evotec's total assets was €1.71B at Dec 31, 2025. For fiscal 2025 it was €1.71B, down 10.4% from the year before. The highest annual figure on record is €2.26B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €1.71B | -10.4% |
| FY2024 | Dec 31, 2024 | €1.91B | -15.1% |
| FY2023 | Dec 31, 2023 | €2.25B | -0.2% |
| FY2022 | Dec 31, 2022 | €2.26B | +1.0% |
| FY2021 | Dec 31, 2021 | €2.24B | +52.8% |
| FY2020 | Dec 31, 2020 | €1.46B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €1.71B | -23.3% |
| Q4 FY2024 | Dec 31, 2024 | €1.91B | +30.8% |
| Q4 FY2023 | Dec 31, 2023 | €2.25B | – |
| Q4 FY2022 | Dec 31, 2022 | €2.26B | – |
| Q4 FY2021 | Dec 31, 2021 | €2.24B | – |
| Q4 FY2020 | Dec 31, 2020 | €1.46B | – |
See a number that looks wrong?